Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Non-Small-Cell Lung 17Prostatic Neoplasms 12Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 5Prostatic Neoplasms, Castration-Resistant 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Endometrial Neoplasms 4Neoplasms 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Oropharyngeal Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Lymphoid Interstitial Pneumonia 2Carcinoma, Transitional Cell 2Carcinoma 2Anatomic Stage II Breast Cancer AJCC v8 2Anatomic Stage I Breast Cancer AJCC v8 2Uterine Neoplasms 1Urothelial Cancer 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage I Prostate Adenocarcinoma AJCC v7 1Solid Tumors 1Small Cell Lung Carcinoma 1Selected Subjects With Advanced Solid Tumors 1

Interventions

Gemcitabine 5Mitomycin 4erdafitinib 3Docetaxel 2viscum album peptide 1durvalumab 1Cystoscopy 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Docetaxel × 30 days × Clear all
NCT06929286 2026-05-11

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting
125 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT05538663 2026-05-05

BRIDGE

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
870 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡